Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

OBJECTIVE: The recent availability of novel antiviral drugs has raised new hope for a more effective treatment of hepatitis C virus (HCV) infection and its severe sequelae. However, in the case of non-responding or relapsing patients, alternative strategies are needed. To this end we have used chime...

Descripción completa

Detalles Bibliográficos
Autores principales: Sautto, Giuseppe A, Wisskirchen, Karin, Clementi, Nicola, Castelli, Matteo, Diotti, Roberta A, Graf, Julia, Clementi, Massimo, Burioni, Roberto, Protzer, Ulrike, Mancini, Nicasio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789830/
https://www.ncbi.nlm.nih.gov/pubmed/25661083
http://dx.doi.org/10.1136/gutjnl-2014-308316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789830/
https://www.ncbi.nlm.nih.gov/pubmed/25661083
http://dx.doi.org/10.1136/gutjnl-2014-308316

Ejemplares similares